Published in Virology on September 01, 1991
Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. Proc Natl Acad Sci U S A (1992) 7.72
Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles. J Virol (1993) 5.12
Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection. J Virol (1995) 4.14
Simultaneous quantitation of antibodies to neutralizing epitopes on virus-like particles for human papillomavirus types 6, 11, 16, and 18 by a multiplexed luminex assay. Clin Diagn Lab Immunol (2003) 3.76
Genital human papillomavirus infection. Proc Natl Acad Sci U S A (1994) 2.12
Biology of human papillomaviruses. Int J Exp Pathol (2001) 1.31
Two amino acid residues confer type specificity to a neutralizing, conformationally dependent epitope on human papillomavirus type 11. J Virol (1996) 1.29
Cottontail rabbit papillomavirus L1 protein-based vaccines: protection is achieved only with a full-length, nondenatured product. J Virol (1993) 1.23
A neutralizing epitope of human papillomavirus type 11 is principally described by a continuous set of residues which overlap a distinct linear, surface-exposed epitope. J Virol (1997) 1.20
Vaccination with HPV16 L2E6E7 fusion protein in GPI-0100 adjuvant elicits protective humoral and cell-mediated immunity. Vaccine (2008) 1.05
Developing vaccines against minor capsid antigen L2 to prevent papillomavirus infection. Immunol Cell Biol (2009) 1.02
Papillomavirus prophylactic vaccines: established successes, new approaches. J Virol (2009) 1.00
Expression pattern and subcellular localization of human papillomavirus minor capsid protein L2. Am J Pathol (2008) 0.92
Production and characterization of human proliferative T-cell clones specific for human papillomavirus type 1 E4 protein. J Virol (1993) 0.86
In planta production of a candidate vaccine against bovine papillomavirus type 1. Planta (2012) 0.84
Sequential cisplatin therapy and vaccination with HPV16 E6E7L2 fusion protein in saponin adjuvant GPI-0100 for the treatment of a model HPV16+ cancer. PLoS One (2015) 0.79
Expression and in Silico analysis of the recombinant bovine papillomavirus E6 protein as a model for viral oncoproteins studies. Biomed Res Int (2013) 0.78
Optimization of heterologous DNA-prime, protein boost regimens and site of vaccination to enhance therapeutic immunity against human papillomavirus-associated disease. Cell Biosci (2016) 0.77
A multimeric L2 vaccine for prevention of animal papillomavirus infections. Virology (2011) 0.76
Papillomaviruses: a systematic review. Genet Mol Biol (2017) 0.75
Progress and prospects for L2-based human papillomavirus vaccines. Expert Rev Vaccines (2016) 0.75
Lack of effect of recombinant bovine interferon alpha I1 in the treatment of experimentally-induced bovine warts. Can J Vet Res (1993) 0.75
Timing of peak bone mass in Caucasian females and its implication for the prevention of osteoporosis. Inference from a cross-sectional model. J Clin Invest (1994) 2.33
Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. Proc Natl Acad Sci U S A (1995) 2.33
Conservation of cytoplasmic poly (A)-containing RNA in mouse and rat. Nature (1975) 2.18
Virus-like particles of bovine papillomavirus type 4 in prophylactic and therapeutic immunization. Virology (1996) 2.08
Evolution of human papillomavirus type 18: an ancient phylogenetic root in Africa and intratype diversity reflect coevolution with human ethnic groups. J Virol (1993) 1.99
Transcriptional control signals in the genome of bovine papillomavirus type 1. Nature (1983) 1.70
Repetitive DNA sequences near three human beta-type globin genes. Nucleic Acids Res (1980) 1.55
Negative regulation of the human epsilon-globin gene by transcriptional interference: role of an Alu repetitive element. Mol Cell Biol (1990) 1.51
Vaccination of cattle with the N-terminus of L2 is necessary and sufficient for preventing infection by bovine papillomavirus-4. Virology (1995) 1.48
Epsilon globin gene transcripts originating upstream of the mRNA cap site in K562 cells and normal human embryos. Nucleic Acids Res (1982) 1.47
Regulation of an IMP dehydrogenase gene and its overexpression in drug-sensitive transcription elongation mutants of yeast. J Biol Chem (2001) 1.45
Persistence of non-integrated viral DNA in bovine cells transformed in vitro by bovine papillomavirus type 2. Nature (1981) 1.35
Vaccination of cattle with bovine papillomavirus type 4 L2 elicits the production of virus-neutralizing antibodies. J Gen Virol (1996) 1.32
Prophylactic and therapeutic vaccination against a mucosal papillomavirus. J Gen Virol (1993) 1.26
Apoptosis, proliferation, and angiogenesis in oral tissues. Possible relevance to tumour progression. J Pathol (2000) 1.25
Variation of human papillomavirus type 6 (HPV-6) and HPV-11 genomes sampled throughout the world. J Clin Microbiol (1995) 1.25
Tandem integration of complete and defective SV40 genomes in mouse-human somatic cell hybrids. Cell (1978) 1.24
A peptide encoding a B-cell epitope from the N-terminus of the capsid protein L2 of bovine papillomavirus-4 prevents disease. Virology (1997) 1.22
Alternative sites of transcription initiation upstream of the canonical cap site in human gamma-globin and beta-globin genes. Nucleic Acids Res (1984) 1.20
High throughput detection of retrovirus-associated reverse transcriptase using an improved fluorescent product enhanced reverse transcriptase assay and its comparison to conventional detection methods. J Virol Methods (1999) 1.17
Two classes of messenger RNA in cultured rat cells: repetitive sequence transcripts and unique sequence transcripts. J Mol Biol (1974) 1.16
Studies on vaccination against papillomaviruses: a comparison of purified virus, tumour extract and transformed cells in prophylactic vaccination. Vet Rec (1990) 1.15
Unintegrated viral DNA sequences in a hamster tumor induced by bovine papilloma virus. J Virol (1981) 1.14
Molecular heterogeneity and lesion site specificity of cutaneous bovine papillomaviruses. Virology (1981) 1.13
Aluminum-induced calcium deficiency syndrome in declining red spruce. Science (1988) 1.11
Virus-induced papillomas of the alimentary tract of cattle. Int J Cancer (1978) 1.11
Studies on vaccination against papillomaviruses: the immunity after infection and vaccination with bovine papillomaviruses of different types. Vet Rec (1990) 1.11
Experimental reproduction of the papilloma-carcinoma complex of the alimentary canal in cattle. Carcinogenesis (1994) 1.09
alpha6 integrin is not the obligatory cell receptor for bovine papillomavirus type 4. J Gen Virol (2000) 1.09
Association of bovine papillomavirus with the equine sarcoid. J Gen Virol (2003) 1.07
The B subgroup bovine papillomaviruses lack an identifiable E6 open reading frame. Mol Carcinog (1991) 1.06
Association of bovine papillomavirus type 2 and bracken fern with bladder cancer in cattle. Cancer Res (1992) 1.06
Multiple interactions between cellular factors and the non-coding region of human papillomavirus type 16. J Gen Virol (1990) 1.01
DNA-RNA hybridization. Philos Trans R Soc Lond B Biol Sci (1975) 0.99
The nucleotide sequence and genome organization of bovine papillomavirus type 4. J Gen Virol (1987) 0.99
Mathematical foundations of computed tomography. Appl Opt (1985) 0.99
Molecular cloning and characterization of human papillomavirus type 7 DNA. Virology (1986) 0.98
A novel bovine papillomavirus (BPV-6) causing true epithelial papillomas of the mammary gland skin: a member of a proposed new BPV subgroup. Virology (1984) 0.98
Down-regulation of MHC class I is a property common to papillomavirus E5 proteins. Virus Res (2006) 0.98
Spinal bone loss in postmenopausal women supplemented with calcium and trace minerals. J Nutr (1994) 0.97
Assessment of vascularity in histological sections: effects of methodology and value as an index of angiogenesis in breast tumours. Histochem J (1998) 0.97
The diagnosis of breast cancer in mammograms by the evaluation of density patterns. Radiology (1977) 0.96
Bovine papillomavirus E5 oncoprotein binds to the activated form of the platelet-derived growth factor beta receptor in naturally occurring bovine urinary bladder tumours. Oncogene (2006) 0.96
Tissue specific transcription of the human epsilon-globin gene following transfection into the embryonic erythroid cell line K562. Nucleic Acids Res (1985) 0.96
The bovine papillomavirus type 4 E8 protein binds to ductin and causes loss of gap junctional intercellular communication in primary fibroblasts. J Virol (1996) 0.95
Repetitious and unique sequences in the heterogeneous nuclear and cytoplasmic messenger RNA of mammalian and insect cells. Cell (1974) 0.92
Characterisation of endogenous retrovirus in rodent cell lines used for production of biologicals. Biologicals (2003) 0.92
Both viral E2 protein and the cellular factor PEBP2 regulate transcription via E2 consensus sites within the bovine papillomavirus type 4 long control region. J Virol (1995) 0.92
Role of different sponge cell types in species specific cell aggregation. Nat New Biol (1971) 0.91
Establishment and characterization of equine fibroblast cell lines transformed in vivo and in vitro by BPV-1: model systems for equine sarcoids. Virology (2008) 0.89
Comparison of electron microscopic techniques for enumeration of endogenous retrovirus in mouse and Chinese hamster cell lines used for production of biologics. J Virol Methods (2003) 0.87
The enhancer in the long control region of human papillomavirus type 16 is up-regulated by PEF-1 and down-regulated by Oct-1. J Virol (1995) 0.87
DNA sequences of human papillomavirus types 11, 16, and 18 in lesions of the uterine cervix in the west of Scotland. Br Med J (Clin Res Ed) (1986) 0.87
Molecularly cloned bovine papillomavirus DNA transforms mouse fibroblasts in vitro. J Gen Virol (1983) 0.86
Human papillomavirus DNA in biopsies of oral tissues. J Gen Virol (1991) 0.86
Validation of in vitro chemosensitivity testing in malignant melanoma. Lancet (1983) 0.86
The biology of papillomaviruses and their role in oncogenesis. Anticancer Res (1985) 0.86
Biosynthesis and distribution of ribosomal particles in the cellular slime mould, Dictyostelium purpureum. J Mol Biol (1970) 0.85
E5 transforming proteins of papillomaviruses do not disturb the activity of the vacuolar H(+)-ATPase. J Gen Virol (2001) 0.85
Heterogeneity in microvascular density in lung tumours: comparison with normal bronchus. Br J Cancer (1998) 0.85
Positive and negative E2-independent regulatory elements in the long control region of bovine papillomavirus type 4. J Gen Virol (1991) 0.85
Sequence variants of bovine papillomavirus E5 detected in equine sarcoids. Virus Res (2003) 0.85
Phenotypical characterization of lymphocytes infiltrating regressing papillomas. J Virol (1996) 0.85
Meal effects on calcium absorption. Am J Clin Nutr (1989) 0.84
Molecular cloning of bovine papillomavirus genomes and comparison of their sequence homologies by heteroduplex mapping. J Gen Virol (1982) 0.84
Presence of beta human papillomaviruses in nonmelanoma skin cancer from organ transplant recipients and immunocompetent patients in the West of Scotland. Br J Dermatol (2009) 0.84
Characterization of a nuclear factor, papilloma enhancer binding factor-1, that binds the long control region of human papillomavirus type 16 and contributes to enhancer activity. Mol Carcinog (1993) 0.84
Quantitative aspects of zinc absorption by isolated, vascularly perfused rat intestine. J Nutr (1980) 0.84
Homophobia: a tentative personality profile. Psychol Rep (1971) 0.83
Coordinate and non-coordinate accululation of aspartate transcarbamylase and dihydroorotase in synchronous Chlorella cells growing on different nitrogen sources. Biochim Biophys Acta (1977) 0.83
Analysis of the transforming functions of bovine papillomavirus type 4. Virology (1993) 0.83